Literature DB >> 6416911

The influence of hyperglycaemia, hyperinsulinaemia and genetic background on the fate of intrasplenically implanted mouse islets.

A Andersson.   

Abstract

We reported recently that intrasplenic transplantation of syngeneic pancreatic islets failed to cure obese-hyperglycaemic mice, despite a considerable growth of the grafted islets. In the present study, the role of sustained hyperglycaemia and hyperinsulinaemia for regeneration of transplanted islet cells was evaluated in these animals. Islets implanted into alloxan-diabetic C57BL/6J mice in numbers insufficient to restore normoglycaemia did not grow. There was, however, a statistically significant correlation between the mean volume of implanted islets and the degree of normalization of hyperglycaemia. Insulin treatment of these suboptimally islet-implanted C57BL/6J mice resulted in a volume increase of the implanted islets. When corresponding experiments were undertaken with alloxan-diabetic C57BL/KsJ mice, no effect was noted on hyperglycaemia and there was a drastic decrease in the volume of implanted islets. Islets implanted into old obese-hyperglycaemic mice that had returned to normoglycaemia but still were hyperinsulinaemic, decreased markedly in size. The present data suggest that neither hyperglycaemia nor hyperinsulinaemia per se are primarily responsible for the growth of islets in obese-hyperglycaemic mice. Furthermore, it is obvious that the genetic background is very important for morphological and functional responses of the islets to a prolonged period of hyperglycaemic stress.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6416911     DOI: 10.1007/BF00279942

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  13 in total

Review 1.  Obese and diabetes: two mutant genes causing diabetes-obesity syndromes in mice.

Authors:  D L Coleman
Journal:  Diabetologia       Date:  1978-03       Impact factor: 10.122

2.  Return to normal of blood-glucose, plasma-insulin, and weight gain in New Zealand obese mice after implantation of islets of Langerhans.

Authors:  R J Gates; M I Hunt; R Smith; N R Lazarus
Journal:  Lancet       Date:  1972-09-16       Impact factor: 79.321

3.  Further studies on the amelioration of the characteristics of New Zealand Obese (NZO) mice following implantation of islets of Langerhans.

Authors:  R J Gates; M I Hunt; N R Lazarus
Journal:  Diabetologia       Date:  1974-10       Impact factor: 10.122

4.  Determination of total serum insulin (IRI) in insulin-treated diabetic patients.

Authors:  L G Heding
Journal:  Diabetologia       Date:  1972-08       Impact factor: 10.122

5.  Development of the obese-hyperglycaemic syndrome in mice.

Authors:  S Westman
Journal:  Diabetologia       Date:  1968-06       Impact factor: 10.122

6.  Insulin and multiplication stimulating activity (an insulin-like growth factor) stimulate islet (beta-cell replication in neonatal rat pancreatic monolayer cultures.

Authors:  A Rabinovitch; C Quigley; T Russell; Y Patel; D H Mintz
Journal:  Diabetes       Date:  1982-02       Impact factor: 9.461

7.  Effects, in tissue culture, of serum from obese mice on the DNA synthesis of the pancreatic B-cell.

Authors:  I Swenne; A J Bone
Journal:  Cell Biol Int Rep       Date:  1981-07

8.  Syngeneic transplantation of fetal rat pancreas. II. Effect of insulin treatment on the growth and differentiation of pancreatic implants fifteen days after transplantation.

Authors:  R C McEvoy; O D Hegre
Journal:  Diabetes       Date:  1978-10       Impact factor: 9.461

9.  Failure of successful intrasplenic transplantation of islets from lean mice to cure obese-hyperglycaemic mice, despite islet growth.

Authors:  A Andersson; U Eriksson; B Petersson; L Reibring; I Swenne
Journal:  Diabetologia       Date:  1981-03       Impact factor: 10.122

10.  Potassium ions and the secretion of insulin by islets of Langerhans incubated in vitro.

Authors:  S L Howell; K W Taylor
Journal:  Biochem J       Date:  1968-06       Impact factor: 3.857

View more
  7 in total

1.  Ducto-insular proliferation of beta-cells after syngeneic islet transplantation into the spleen of streptozotocin-diabetic Lewis rats.

Authors:  F Wohlrab; S Schmidt; I Klöting; B Wilke; L Cossel
Journal:  Int J Pancreatol       Date:  1989-07

2.  Islet transplantation outcomes in mice are better with fresh islets and exendin-4 treatment.

Authors:  A King; J Lock; G Xu; S Bonner-Weir; G C Weir
Journal:  Diabetologia       Date:  2005-08-23       Impact factor: 10.122

3.  Hyperglycemia-induced B cell toxicity. The fate of pancreatic islets transplanted into diabetic mice is dependent on their genetic background.

Authors:  O Korsgren; L Jansson; S Sandler; A Andersson
Journal:  J Clin Invest       Date:  1990-12       Impact factor: 14.808

4.  Effect of genetic background on the capacity for islet cell replication in mice.

Authors:  I Swenne; A Andersson
Journal:  Diabetologia       Date:  1984-10       Impact factor: 10.122

5.  Beta cell mass and growth after syngeneic islet cell transplantation in normal and streptozocin diabetic C57BL/6 mice.

Authors:  E Montaña; S Bonner-Weir; G C Weir
Journal:  J Clin Invest       Date:  1993-03       Impact factor: 14.808

6.  A simple matter of life and death-the trials of postnatal Beta-cell mass regulation.

Authors:  Elena Tarabra; Stella Pelengaris; Michael Khan
Journal:  Int J Endocrinol       Date:  2012-04-22       Impact factor: 3.257

Review 7.  The Spleen as an Optimal Site for Islet Transplantation and a Source of Mesenchymal Stem Cells.

Authors:  Naoaki Sakata; Gumpei Yoshimatsu; Shohta Kodama
Journal:  Int J Mol Sci       Date:  2018-05-07       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.